3933 — United Laboratories International Holdings Income Statement
0.000.00%
Last trade - 00:00
- HK$19.22bn
- HK$16.25bn
- CNY13.74bn
- 97
- 64
- 100
- 99
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 8,393 | 8,772 | 9,703 | 11,334 | 13,740 |
Cost of Revenue | |||||
Gross Profit | 3,621 | 3,806 | 4,211 | 4,969 | 6,335 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 7,270 | 7,709 | 8,441 | 9,246 | 10,329 |
Operating Profit | 1,122 | 1,064 | 1,263 | 2,089 | 3,411 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 842 | 882 | 1,203 | 2,007 | 3,344 |
Provision for Income Taxes | |||||
Net Income After Taxes | 642 | 701 | 990 | 1,581 | 2,701 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 642 | 703 | 988 | 1,581 | 2,701 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 642 | 703 | 988 | 1,581 | 2,701 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.302 | 0.378 | 0.547 | 0.906 | 1.51 |
Dividends per Share | |||||
Special Dividends per Share |